Celularity Inc
Celularity Inc
Insider Sentiment (TTM):
Last Purchase:2024-01-12Last Sale:2023-10-05Shares Purchased (TTM):0Shares Sold (TTM):0
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:2,156,255Shares Outstanding:25,598,586Institutional Ownership Pct.:8.42%
Earnings Market Reaction:
Filing Date:2026-04-30Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 6 | 0 | 1 | 0 | 1 | 0 | 0 | 2 | 0 | 0 | 3 | 9 | |||||
Accounts And Other Receivables Net Current | 5 | 7 | 11 | 15 | 14 | 9 | 13 | 14 | 10 | 4 | 3 | 3 | |||||
Inventory Net | 1 | 3 | 4 | 6 | 5 | 4 | 3 | 4 | 6 | 5 | 6 | 5 | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 5 | 4 | 6 | |||||
Assets Current | 12 | 11 | 17 | 22 | 21 | 15 | 18 | 23 | 20 | 16 | 18 | 25 | |||||
Assets Noncurrent | |||||||||||||||||
Property Plant And Equipment Net | 56 | 57 | 59 | 60 | 62 | 63 | 65 | 66 | 68 | 71 | 73 | 74 | |||||
Long Term Investments | - | 3 | - | - | - | - | - | - | - | - | - | - | |||||
Goodwill | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 90 | 90 | |||||
Intangible Assets Net Excluding Goodwill | 8 | 8 | 9 | 9 | 9 | 10 | 10 | 10 | 11 | 12 | 12 | 120 | |||||
Operating Lease Right Of Use Asset | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 13 | 13 | |||||
Restricted Cash Noncurrent | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 15 | 15 | 15 | |||||
Inventory Noncurrent | 3 | 7 | 7 | 9 | 13 | 13 | 14 | 16 | 17 | 25 | 25 | 25 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 107 | 114 | 120 | 129 | 133 | 129 | 135 | 144 | 144 | 157 | 246 | 362 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 26 | 25 | 24 | 23 | 23 | 15 | 14 | 13 | 14 | 13 | 12 | 9 | |||||
Accrued Liabilities And Other Liabilities | 33 | 29 | 33 | 25 | 20 | 14 | 10 | 9 | 8 | 10 | 9 | 10 | |||||
Short Term Borrowings | - | - | - | - | - | - | - | - | 17 | 14 | 17 | 31 | |||||
Contract With Customer Liability Current | 5 | 6 | 4 | 3 | 4 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | |||||
Asset Acquisition Contingent Consideration Liabili… | - | - | - | - | 1 | - | - | - | - | - | - | - | |||||
Other Liabilities Current | 0 | - | - | - | - | - | - | - | - | - | - | - | |||||
Derivative Liabilities Current | 0 | - | - | - | - | - | - | - | - | - | - | - | |||||
Liabilities Current | 81 | 65 | 69 | 59 | 54 | 76 | 68 | 66 | 67 | 85 | 65 | 66 | |||||
Liabilities Noncurrent | |||||||||||||||||
Contract With Customer Liability Noncurrent | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 87 | |||||
Asset Acquisition Contingent Consideration Liabili… | - | 1 | 1 | 1 | 1 | - | - | - | 2 | - | - | - | |||||
Business Combination Contingent Consideration Liab… | 1 | - | - | - | 1 | - | - | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 27 | 27 | 27 | 27 | 27 | 26 | 26 | 26 | 26 | 26 | 28 | 28 | |||||
Long Term Debt | - | - | - | - | - | - | - | - | - | - | 17 | 5 | |||||
Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 145 | 134 | 146 | 134 | 124 | 112 | 108 | 113 | 103 | 127 | 128 | 207 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 953 | 947 | 919 | 914 | 909 | 904 | 898 | 895 | 883 | 879 | 874 | 862 | |||||
Retained Earnings Accumulated Deficit | -991 | -967 | -944 | -920 | -900 | -886 | -870 | -864 | -842 | -851 | -757 | -710 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | - | - | -0 | - | -0 | -0 | - | - | - | 2 | 2 | 3 | |||||
Stockholders Equity | -38 | -20 | -25 | -6 | 9 | 17 | 28 | 31 | 41 | 30 | 119 | 156 | |||||
Liabilities And Stockholders Equity | 107 | 114 | 120 | 129 | 133 | 129 | 135 | 144 | 144 | 157 | 246 | 362 | |||||
Shortterm Debt Fair Value | - | - | - | - | 2 | 4 | 3 | 2 | 17 | 14 | 17 | 31 | |||||
Allowance For Doubtful Accounts Receivable Current | 8 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 2 | 2 | 2 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Debt Default Shortterm Debt Amount | - | - | - | - | - | - | - | - | 17 | 17 | 17 | 32 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 730 | 730 | 730 | 730 | 730 | 730 | 730 | 730 | 730 | 730 | 730 | 730 | |||||
Common Stock Shares Issued | 29 | 28 | 25 | 24 | 23 | 22 | 22 | 22 | 19 | 19 | 18 | 17 | |||||
Shares Outstanding | 29 | 28 | 25 | 24 | 23 | 22 | 22 | 22 | 19 | 19 | 18 | 17 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | -43.65% | -49.75% | -60.66% | 27.74% | -21.94% | -21.29% | -6.85% | -19.49% | -16.49% |
| 2024 | 27.70% | -15.11% | -17.27% | -33.98% | -27.51% | -19.09% | -5.08% | 5.93% | -28.81% | 27.11% | 11.45% | 78.31% |
| 2023 | 20.00% | -26.22% | -52.59% | 1.92% | -30.35% | -25.24% | 22.06% | 65.12% | 84.70% | 5.72% | -0.33% | -16.05% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.15 | 0.16 | 0.25 | 0.38 | 0.38 | 0.19 | 0.26 | 0.35 | 0.29 | 0.19 | 0.28 | 0.38 | |||||
| Quick Ratio | 0.13 | 0.10 | 0.17 | 0.26 | 0.27 | 0.12 | 0.21 | 0.27 | 0.18 | 0.08 | 0.12 | 0.21 | |||||
| Working Capital | -68.44M | -54.72M | -51.96M | -36.61M | -33.12M | -61.67M | -50.17M | -43.19M | -47.51M | -68.13M | -46.94M | -41.45M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -3.82 | -6.69 | -5.72 | -24.41 | 14.01 | 6.46 | 3.87 | 3.60 | 2.51 | 4.20 | 1.08 | 1.33 | |||||
| Debt Ratio | 1.35 | 1.18 | 1.21 | 1.04 | 0.93 | 0.87 | 0.79 | 0.78 | 0.72 | 0.81 | 0.52 | 0.57 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.22 | 0.33 | 0.35 | 0.37 | 0.39 | 0.34 | 0.22 | 0.13 | 0.08 | 0.05 | 0.04 | 0.04 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -3.59 | -3.06 | -3.07 | -2.36 | -2.64 | -1.60 | -5.16 | -7.20 | -11.02 | -9.63 | -4.69 | 0.84 | |||||
| Free Cash Flow Per Share TTM | -0.52 | -0.25 | -0.11 | -0.22 | -0.30 | -0.59 | -0.98 | -1.35 | -2.23 | -3.46 | -5.43 | -7.89 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 24.39% | 50.61% | 55.10% | 66.83% | 72.36% | 64.20% | 60.24% | 53.30% | 29.66% | 52.33% | 71.86% | 75.70% | |||||
| Operating Profit Margin TTM | -230.92% | -119.60% | -105.76% | -81.37% | -70.75% | -32.70% | -242.43% | -405.15% | -844.44% | -1,272.09% | -624.34% | -299.57% | |||||
| Net Profit Margin TTM | -345.76% | -198.75% | -165.22% | -109.16% | -106.77% | -72.73% | -264.30% | -460.34% | -862.04% | -1,226.72% | -546.56% | 81.64% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -51.03% | -15.81% | 4.45% | 52.06% | 138.11% | 225.94% | 182.02% | 109.81% | 26.68% | -20.93% | -39.91% | -35.09% | |||||
| Net Income Growth (1Y) | 58.57% | 130.07% | -34.71% | -63.94% | -70.51% | -80.68% | 36.38% | -1,283.03% | -1,483.14% | 1,170.19% | -368.12% | -116.01% | |||||
| EPS Growth (1Y) | 35.60% | 91.90% | -40.61% | -67.15% | -76.00% | -83.44% | 10.20% | -957.25% | -1,186.34% | 862.35% | -312.83% | -113.44% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.31 | -0.68 | -0.64 | -0.73 | -0.79 | -1.86 | -0.61 | -0.73 | -0.22 | -0.23 | -1.14 | 7.39 | |||||
| P/B TTM | -0.75 | -2.71 | -1.85 | -7.39 | 5.15 | 3.78 | 2.46 | 3.59 | 1.07 | 1.38 | 0.79 | 0.62 | |||||
| P/S TTM | 1.07 | 1.34 | 1.06 | 0.80 | 0.84 | 1.35 | 1.60 | 3.35 | 1.93 | 2.83 | 6.22 | 6.03 | |||||
| Market Cap | 28.41M | 54.54M | 47.08M | 40.71M | 45.53M | 65.27M | 68.39M | 112.14M | 44.00M | 41.81M | 94.11M | 96.33M | |||||
| Enterprise Value | 12.04M | 44.28M | 36.14M | 30.40M | 34.56M | 54.94M | 57.84M | 100.19M | 51.06M | 40.71M | 110.04M | 108.66M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -13.25M | -6.65M | -2.63M | -5.11M | -6.56M | -12.99M | -21.39M | -28.97M | -39.73M | -65.18M | -95.91M | -122.61M | |||||
| Net Debt | -16.37M | -10.26M | -10.94M | -10.30M | -10.98M | -10.33M | -10.55M | -11.95M | 7.06M | -1.09M | 15.93M | 12.33M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2024-01-12Purchase
Owner: Genting, Berhad, Dragasac…
Title: -
Shares: 21,410,983
Price/Share: $0.25
Value: $5,352,745.75
Shares Owned: 51,473,762
Relationship: TenPercentOwner
Ownership: Indirect
2023-10-05Purchase
Owner: Hariri, Robert J
Title: Chief Executive Officer
Shares: 9,357,585
Price/Share: $0.16
Value: $1,497,213.60
Shares Owned: 28,570,434
Relationship: Director,Officer
Ownership: Direct
2023-10-05Sale
Owner: Sorrento, Therapeutics, I…
Title: -
Shares: 6,307,158
Price/Share: -
Value: -
Shares Owned: 5,050,427
Relationship: TenPercentOwner
Ownership: Direct
2022-11-30Purchase
Owner: Hariri, Robert J
Title: Chief Executive Officer
Shares: 10,000
Price/Share: $1.72
Value: $17,200.00
Shares Owned: 8,074,996
Relationship: Director,Officer
Ownership: Direct
2022-11-29Purchase
Owner: Hariri, Robert J
Title: Chief Executive Officer
Shares: 40,000
Price/Share: $1.71
Value: $68,400.00
Shares Owned: 8,064,996
Relationship: Director,Officer
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
8.42%
Inst. Shares: 2,156,255
Shares Outstanding: 25,598,586
2025-12-31
8.65%
Inst. Shares: 2,213,504
Shares Outstanding: 25,598,586
2025-09-30
8.59%
Inst. Shares: 2,262,329
Shares Outstanding: 26,347,818
2025-06-30
8.11%
Inst. Shares: 1,947,907
Shares Outstanding: 24,020,193
2025-03-31
8.29%
Inst. Shares: 1,950,441
Shares Outstanding: 23,530,877
Celularity Inc (CELU) — SEC Financial Statements & Analysis
Celularity Inc (CELU) is a pharmaceutical preparations company, incorporated in DE. Celularity Inc trades on Nasdaq as: CELU, CELUW. Based on its latest SEC filing (Form 10-Q, period ending 2025-12-31), Celularity Inc reported a -51.03% year-over-year revenue growth, a Gross Profit Margin of 24.39% (TTM), a Debt-to-Equity ratio of -3.82x, a Price-to-Sales (P/S) ratio of 1.07x (TTM), a Price-to-Book (P/B) ratio of -0.75 (TTM), at a market cap of $28.41M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -51.03%
- Gross Profit Margin TTM
- 24.39%
- Debt To Equity
- -3.82x
- P/S TTM
- 1.07x
- P/B TTM
- -0.75
- Market Cap
- $28.41M
Data as of 2025-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Celularity Inc in?
Celularity Inc (CELU) operates in the Pharmaceutical Preparations industry.
What is CELU's market cap?
Celularity Inc (CELU) has a market capitalization of $28.41M as of 2025-12-31.
What exchange does CELU trade on?
Celularity Inc (CELU) trades on the Nasdaq.
Where is Celularity Inc incorporated?
Celularity Inc is incorporated in DE.